IOWA LUTHERAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $522K
- Transactions
- 167
- Companies
- 40
- Average per transaction
- $3,127
Who reported the payments
| Jazz Pharmaceuticals Inc. | $136,125 |
| E.r. Squibb & Sons, L.L.C. | $74,482 |
| Stryker | $68,168 |
| Exact Sciences | $51,500 |
| Angiodynamics, Inc. | $45,250 |
| Roche Diagnostics Corporation | $37,300 |
| Abbott | $28,212 |
| Siemens Medical Solutions USA, Inc. | $15,049 |
| AstraZeneca | $11,930 |
| Arjo Inc. | $7,500 |
| Biogen | $6,884 |
| Incyte Corporation | $6,017 |
| Pfizer | $3,936 |
| Boston Scientific | $3,503 |
| Astrazeneca UK Limited | $3,170 |
| CSL Behring | $2,159 |
| Genentech USA, Inc. | $2,100 |
| Pinnacle Biologics, Inc | $1,650 |
| Endologix LLC | $1,536 |
| AbbVie | $1,500 |
| Pharmacyclics LLC, An Abbvie Company | $1,400 |
| Sanofi Pasteur Inc. | $1,400 |
| Novartis | $1,400 |
| Sanofi | $1,200 |
| Advanced Respiratory, Inc | $1,000 |
| Taiho Oncology, Inc. | $900 |
| Sobi, Inc | $700 |
| G1 Therapeutics, Inc. | $500 |
| Astellas Pharma US Inc | $500 |
| Adaptive Biotechnologies Corporation | $500 |
| Ipsen Biopharmaceuticals, Inc | $500 |
| Agios Pharmaceuticals, Inc. | $500 |
| Lilly USA, LLC | $500 |
| Servier Pharmaceuticals LLC | $500 |
| Blueprint Medicines Corporation | $500 |
| Eisai Inc. | $400 |
| Johnson & Johnson | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | $400 |
| Bard Peripheral Vascular, Inc. | $262 |
| Seagen Inc. | $250 |